Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is F  [Clear All Filters]
2024
Hendrawan S, Lheman J, Weber U, Oberkofler CEugen, Eryani A, Vonlanthen R, Baer HUlrich. Fibroblast matrix implants - a better alternative for incisional hernia repair?. Biomed Mater. 2024.
Huang F, Wei G, Wang H, Zhang Y, Lan W, Xie Y, Wu G. Fibroblasts inhibit osteogenesis by regulating nuclear-cytoplasmic shuttling of YAP in mesenchymal stem cells and secreting DKK1. Biol Res. 2024;57(1):4.
Wang K, Zhou M, Zhang Y, Jin Y, Xue Y, Mao D, Rui Y. Fibromodulin facilitates the osteogenic effect of Masquelet's induced membrane by inhibiting the TGF-β/SMAD signaling pathway. Biomater Sci. 2024.
Liu YLiam, Tang XThomas, Shu HSophie, Zou W, Zhou BO. Fibrous periosteum repairs bone fracture and maintains the healed bone throughout mouse adulthood. Dev Cell. 2024.
He T, Wang Y, Wang R, Yang H, Hu X, Pu Y, Yang BB, Zhang J, Li J, Huang C, et al. Fibrous topology promoted pBMP2-activated matrix on titanium implants boost osseointegration. Regen Biomater. 2024;11:rbad111.
Hu W-C, Tsai J-C, Cheng H-W, Huang C-H, Raja JAJ, Chang F-Y, Chen C-C, Chiang C-H, Yeh S-D. The fifth residue of the coat protein of turnip mosaic virus is responsible for long-distance movement in a local-lesion host and aphid transmissibility in a systemic host. Phytopathology. 2024.
Gao S, He L, Lam CKeung, Taylor MRG, Mestroni L, Lombardi R, Chen SNee. Filamin C Deficiency Impairs Sarcomere Stability and Activates Focal Adhesion Kinase through PDGFRA Signaling in Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Cells. 2024;13(3).
Gascon P, Harbeck N, Rapoport BL, Anderson R, Brueckmann I, Howe S, Aapro M. Filgrastim biosimilar (EP2006): a review of 15 years' post-approval evidence. Crit Rev Oncol Hematol. 2024:104306.
Li Y, Huang H, Gu C, Huang W, Chen X, Lu X, You A, Ye S, Zhong J, Zhao Y, et al. Film-forming polymer solutions containing cholesterol myristate and berberine mediate pressure ulcer repair via the Wnt/β-catenin pathway. Wound Repair Regen. 2024.
DiNardo CDD, Roboz GJ, Watts JM, Madanat YF, Prince GT, Baratam P, de Botton S, Stein AS, Foran JM, Arellano ML, et al. Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood Adv. 2024.
Shatara M, Blue M, Stanek J, Liu YA, Prevedello DM, Giglio P, Puduvalli VK, Gardner SL, Allen JC, Wong KK, et al. Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors. Neurooncol Pract. 2024;11(2):188-198.
Ogawa T, Hirai N, Fujikura H, Imakita N, Kasahara K. Financial Burden as a Potential Barrier to Vaccine Completion in Post-hematopoietic Stem Cell Transplant Patients in Japan. Cureus. 2024;16(3):e56842.
Meissner B, Lang P, Bader P, Hoenig M, Müller I, Meisel R, Greil J, Sauer MG, Metzler M, Corbacioglu S, et al. Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression. Bone Marrow Transplant. 2024.
Makkar D, Gakhar D, Mishra V, Rakha A. Fine Tuning Mesenchymal Stromal Cells - Code For Mitigating Kidney Diseases. Stem Cell Rev Rep. 2024.
Jo T, Ueda T, Akahoshi Y, Kondo T, Uchida N, Tanaka M, Nakamae H, Doki N, Ota S, Sawa M, et al. First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. Br J Haematol. 2024.
Holeva MC, Glynos PE, Reppa C, Karafla CD. First report of causing bacterial wilt on sp. in Greece. Plant Dis. 2024.
Guo Q, Jiang Y, Zeng Y. First report of causing dragon fruit () stem spot in China. Plant Dis. 2024.
Shiozawa Y, Fujita S, Nannya Y, Ogawa S, Nomura N, Kiguchi T, Sezaki N, Kudo H, Toyama T. First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants. Int J Hematol. 2024.
Kanetaka K, Maruya Y, Higashi M, Yamaguchi S, Matsumoto R, Kobayashi S, Hashiguchi K, Oohashi F, Matsumura M, Naka T, et al. A first-in-human clinical study of laparoscopic autologous myoblast sheet transplantation to prevent delayed perforation after duodenal endoscopic mucosal dissection. Stem Cell Res Ther. 2024;15(1):117.
Hughes KA, Misra B, Maghareh M, Samart P, Nguyen E, Hussain S, Geldenhuys WJ, Bobbala S. Flash nanoprecipitation allows easy fabrication of pH-responsive acetalated dextran nanoparticles for intracellular release of payloads. Discov Nano. 2024;19(1):4.
Mir SAhmad, Dar A, Hamid L, Nisar N, Malik JAhmad, Ali T, Bader GNabi. Flavonoids as promising molecules in the cancer therapy: An insight. Curr Res Pharmacol Drug Discov. 2024;6:100167.
Saupe M, Wiedemeier S, Gastrock G, Römer R, Lemke K. Flexible Toolbox of High-Precision Microfluidic Modules for Versatile Droplet-Based Applications. Micromachines (Basel). 2024;15(2).
Kana S, John S, Basu D, Kar R, Ganesh RNachiappa, Dubashi B. Flow Cytometric Assessment of CD26-Positive Leukemic Stem Cells: A Rapid and Valuable Tool in the Diagnosis and Follow-Up of Chronic Myeloid Leukemia. Cureus. 2024;16(3):e56944.
Woost PG, William BM, Cooper BW, Oshima MUeda, Otegbeye F, De Lima MJ, Wald D, Mahfouz RZ, Saunthararajah Y, Stefan T, et al. Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies. Cytometry B Clin Cytom. 2024.
Lucero J, Alhumaid M, Novitzky-Basso I, Capo-Chichi J-M, Stockley T, Gupta V, Bankar A, Chan S, Schuh AC, Minden M, et al. Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2024.

Pages